Xiaobin Cui
Nanjing Drum Tower Hospital(CN)
Publications by Year
Research Areas
Esophageal Cancer Research and Treatment, RNA modifications and cancer, Cancer-related Molecular Pathways, Epigenetics and DNA Methylation, Ferroptosis and cancer prognosis
Most-Cited Works
- → Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression(2019)476 cited
- → Tumor suppressor microRNA-34a inhibits cell migration and invasion by targeting MMP-2/MMP-9/FNDC3B in esophageal squamous cell carcinoma(2017)72 cited
- → PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma(2016)56 cited
- → Inactivation of miR-34a by aberrant CpG methylation in Kazakh patients with esophageal carcinoma(2014)49 cited
- → Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma(2015)47 cited
- → Multiple polymorphisms within the PLCE1 are associated with esophageal cancer via promoting the gene expression in a Chinese Kazakh population(2013)43 cited
- → Paclitaxel-betulinic acid hybrid nanosuspensions for enhanced anti-breast cancer activity(2018)43 cited
- Genetic variation in miR-100 rs1834306 is associated with decreased risk for esophageal squamous cell carcinoma in Kazakh patients in northwest China.(2015)
- → SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma(2015)41 cited
- → Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma(2019)38 cited